The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up UPDATE

Wed, 12th Mar 2014 09:03

Ashtead Group: Citi raises target price from 850p to 1075p keeping a buy recommendation.Barratt Developments: Goldman Sachs reduces target price from 527p to 502p and downgrades to neutral.British Land: Jefferies downgrades to hold with a target price of 707p.Brooks Macdonald Group: Canaccord Genuity increases target price from 1620p to 1780p, but downgrades from buy to hold.Brown (N) Group: UBS lowers target price from 565p to 535p and downgrades from neutral to sell.Cape: Canaccord Genuity ups target price from 300p to 360p maintaining a buy recommendation.Close Brothers Group: Berenberg raises target price from 1330p to 1640p and maintains a buy recommendation. JP Morgan increases target price from 1357p to 1480p and stays with its overweight rating. UBS raises target price from 1340p to 1420p maintaining a neutral rating.Countrywide: Goldman Sachs ups target price from 748p to 764p, while downgrading to neutral.Craneware: Investec raises target price from 615p to 645p keeping a buy recommendation.Crest Nicholson Holdings: Goldman Sachs shifts target price from 525p to 530p and upgrades to strong buy.esure Group: Deutsche Bank moves target price from 300p to 313p and keeps a buy recommendation. Citi shifts target price from 291p to 294p retaining a buy recommendation. Canaccord Genuity lowers target price from 305p to 295p maintaining its buy recommendation.Fenner: Jefferies lowers target price from 505p to 490p, while staying with its buy recommendation. Espirito Santo cuts target price from 410p to 400p and retains its neutral rating. UBS cuts target price from 500p to 480p leaving its buy recommendation unaltered.Go-Ahead Group: Deutsche Bank increases target price from 1640p to 2100p, while downgrading to hold. RBC Capital raises target price from 1800p to 2300p keeping its neutral rating.Hangar8: Westhouse Securities takes target price from 270p to 310p, but downgrades to add.Hikma Pharmaceuticals: Panmure Gordon ups target price from 1375p to 1400p, while downgrading from buy to hold.Hummingbird Resources: Cantor Fitzgerald moves target price from 68p to 80p leaving its buy recommendation unchanged.Hunting: Investec ups target price from 830p to 890p, but downgrades from buy to hold.IFG Group: N+1 Singer upgrades to buy with a target price of 150p.IMI: RBC Capital cuts target price from 1600p to 1550p and retains an outperform rating. Espirito Santo raises target price from 1530p to 1650p and upgrades to buy.Inchcape: Deutsche Bank ups target price from 655p to 685p and reiterates its hold recommendation. Nomura takes target price from 580p to 600p and maintains its neutral rating.Inmarsat: Jefferies moves target price from 790p to 800p and retains a buy recommendation.International Consolidated Airlines Group: Liberum Capital takes target price from 450p to 550p and keeps a buy recommendation.Kazakhmys: UBS raises target price from 210p to 300p and maintains a neutral rating.Land Securities: Jefferies downgrades to hold with a target price of 1112p.Merlin Entertainment: JP Morgan moves target price from 415p to 430p and maintains an overweight rating.Modern Water: Numis cuts target price from 77p to 62p, while its buy recommendation remains unchanged.Morgan Advanced Materials: Espirito Santo raises target price from 280p to 320p and retains a neutral rating.Persimmon: Goldman Sachs cuts target price from 1892p to 1840p and downgrades from strong buy to buy.Phoenix IT: Panmure Gordon lowers target price from 144p to 136p, while upgrading from hold to buy.Plethora Solutions: Daniel Stewart moves shifts target price from 18.9p to 25.6p and keeps a buy recommendation.Premier Farnell: UBS lowers target price from 240p to 235p and stays with its neutral rating.Redrow: Goldman Sachs raises target price from 341p to 423p upgrading to buy.Rentokil Initial: Credit Suisse ups target price from 95p to 125p and keeps a neutral rating.Rightmove: Goldman Sachs reduces target price from 4360p to 3607p and downgrades from strong buy to buy.Rockhopper Exploration: Canaccord Genuity reduces target price from 345p to 265p, but stays with its buy recommendation.Rotork: Espirito Santo increases target price from 2500p to 2600p and stays with its neutral rating.Servelec Group: Investec raises target price from 284p to 310p and maintains its buy recommendation.Spirax-Sarco Engineering: Espirito Santo raises target price from 3000p to 3200p and reiterates a neutral rating.Travis Perkins: Berenberg cuts target price from 1880p to 1800p and retains a hold recommendation.Tyman: Numis raises target price from 285p to 320p reiterating an add rating.WEIR Group: Espirito Santo raises target price from 2600p to 2800p and maintains a buy recommendation.
More News
20 Apr 2022 09:16

IN BRIEF: Hikma gets preliminary US approval for Custopharm acquisition

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Receives preliminary approval from the US Federal Trade Commission for its planned acquisition of Custopharm Inc. Back in September, Hikma agreed to buy the California, US-based generic injectable products company for a total of up to USD425 million.

Read more
20 Apr 2022 07:39

Hikma gets preliminary approval from US FTC for Custopharm deal

(Sharecast News) - Hikma Pharmaceuticals has received preliminary approval from the US Federal Trade Commission for the acquisition of sterile injectables company Custopharm Inc from Water Street Healthcare for up to $425m.

Read more
12 Apr 2022 10:11

LONDON BROKER RATINGS: JPMorgan lowers Rolls-Royce; UBS likes Ryanair

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
10 Mar 2022 16:10

UK dividends calendar - next 7 days

Friday 11 March  
Avon Protection PLCdividend payment date
Civitas Social Housing PLCdividend payment date
Impact Healthcare REIT PLCdividend payment date
Virgin Money UK PLCdividend payment date
Monday 14 March  
Tritax EuroBox PLCdividend payment date
Tuesday 15 March 
Hipgnosis Songs Fund Ltddividend payment date
Invesco Perpetual UK Smaller Cos Investment Trust PLCdividend payment date
Merchants Trust PLCdividend payment date
Wednesday 16 March  
no events scheduled 
Thursday 17 March  
Anglo American PLCex-dividend date
Anglo American PLCspecial ex-dividend date
Bellevue Healthcare Trust PLCex-dividend date
Blackrock Income & Growth Investment Trust PLCdividend payment date
BlacKRock World Mining Trust PLCex-dividend date
Brooks Macdonald Group PLCex-dividend date
Crest Nicholson Holdings PLCex-dividend date
Dunelm Group PLCex-dividend date
FW Thorpe PLCex-dividend date
FW Thorpe PLCspecial ex-dividend date
Gore Street Energy Storage Fund PLCex-dividend date
HgCapital Trust PLCex-dividend date
Hikma Pharmaceuticals PLCex-dividend date
Ideagen PLCdividend payment date
JPMorgan Mid Cap Investment Trust PLCex-dividend date
Knights Group Holdings PLCdividend payment date
M&G PLCex-dividend date
Murray Income Trust PLCdividend payment date
NatWest Group PLCex-dividend date
RM PLCex-dividend date
Segro PLCex-dividend date
Spirent Communications PLCex-dividend date
Standard Life Private Equity Trust PLCex-dividend date
Treatt PLCdividend payment date
Trifast PLCex-dividend date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
3 Mar 2022 10:02

LONDON BROKER RATINGS: Downgrades for Hikma Pharma and Royal Mail

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
3 Mar 2022 08:28

LONDON BRIEFING: LSEG says Refinitiv savings bigger, ahead of schedule

(Alliance News) - London Stock Exchange Group on Thursday said 2021 was a successful year following the acquisition of Refinitiv, leaving the stock exchange operator well positioned as a financial market infrastructure and data business.

Read more
2 Mar 2022 09:52

LONDON BROKER RATINGS: Downgrades for AB Foods, BT and Royal Mail

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 Feb 2022 09:40

IN BRIEF: Hikma Pharmaceuticals launches first phase of share buyback

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Instructs Citigroup Global Markets Ltd, part of Citigroup Inc, to conduct the USD150 million first tranche of the USD300 million share buyback that it announced on Thursday. The initial phase will begin on Friday and end by June 25. Hikma had announced the buyback programme with its annual results, saying it reflected its strong cash generation, balance sheet strength, and confidence in future growth prospects. Hikma also had declared a final dividend of 36 cents, a 5.9% boost from a shareholder payout of 34 cents the year before. Its full-year dividend amounted to 54 US cents, up 8.0% from 50 cents.

Read more
25 Feb 2022 08:22

LONDON BRIEFING: IAG expects to fly 85% of pre-virus capacity in 2022

(Alliance News) - International Consolidated Airlines Group on Friday posted a narrowed loss for 2021, saying that after the setback caused by Omicron at the end of the year, bookings have rebounded strongly and it expects to fly 85% of its 2019 capacity in 2022.

Read more
24 Feb 2022 10:31

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and lifted its shareholder payout.

Read more
24 Feb 2022 07:58

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strategic momentum", with both revenue and operating profits improving year-on-year.

Read more
24 Feb 2022 07:50

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale war in eastern Europe after Russia announced the beginning of a military operation in Ukraine.

Read more
17 Feb 2022 16:08

UK earnings, trading statements calendar - next 7 days

Friday 18 February  
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 21 February 
Bank of Cyprus Holdings PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Tristel PLCTrading Statement
Wilmington PLCHalf Year Results
Tuesday 22 February 
Antofagasta PLCFull Year Results
Bank of Georgia Group PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Blancco Technology Group PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Coca-Cola HBC AGFull Year Results
Hargreaves Lansdown PLCHalf Year Results
HSBC Holdings PLCFull Year Results (at 0400 GMT)
InterContinental Hotels Group PLCFull Year Results
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Synectics PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wednesday 23 February 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Barclays PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
CAP-XX LtdHalf Year Results
Georgia Capital PLCFull Year Results
International Personal Finance PLCFull Year Results
Irish Residential Properties REIT PLCFull Year Results
Metro Bank PLCFull Year Results
Hochschild Mining PLCFull Year Results
Photo-Me International PLCFull Year Results
Rio Tinto PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCFull Year Results
Thursday 24 February 
Anglo American PLCFull Year Results
BAE Systems PLCFull Year Results
Centrica PLCFull Year Results
Conduit Holdings LtdFull Year Results
Derwent London PLCFull Year Results
Drax Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Inchcape PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Rathbone Group PLCFull Year Results
Ricardo PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
St James's Place PLCFull Year Results
Tremor International LtdFull Year Results
WPP PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.